Browsing by Research field "M 003 - Farmacija / Pharmacy"

Now showing items 1-7 of 7

    • Antihypertensive medicine use in the Baltic states between 2008 and 2018 

      Trečiokienė, Indrė; Bratčikovienė, Nomeda; Gulbinovič, Jolanta; Wettermark, Bjorn; Taxis, Katja (Pharmacoepidemiology and drug safety: Supplement: Special Issue: Abstracts of the 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, September 16–17, 2020, 2020)

    • Different stabilization techniques for type 62B3 acetabular fractures in combination with primary total hip arthroplasty in elderly patients: a biomechanical comparison 

      Uvarovas, Valentinas; Šatkauskas, Igoris; Urbanavičius, Robertas; Bučinskas, Vytautas; Griškevičius, Julius; Vengrauskas, Vytautas; Petryla, Giedrius; Masionis, Povilas; Andrijauskas, Audrius; Porvaneckas, Narūnas (Geriatric Orthopaedic Surgery & Rehabilitation, 2016)
      Introduction: The total hip arthroplasty (THA) as part of acute fracture management is used for acetabular fractures in elderly patients. Our objective was to assess the stability of osteosynthesis performed using 2 different ...

    • Ethical aspects of pharmacogenetics: a need for creativity 

      Grincevičienė, Vilija; Valatka, Vytis; Grincevičius, Jonas; Grincevičienė, Švitrigailė (Filosofija. Sociologija, 2015)
      The article attempts to reveal the need and issues of creative application of pharmacogenetics in physician’s work. Creativity is interpreted based on the concept proposed by Guil - ford (1971). The proposed major thesis ...

    • Non-persistence to antihypertensive drug therapy in Lithuania 

      Trečiokienė, Indrė; Bratčikovienė, Nomeda; Gulbinovič, Jolanta; Wettermark, Bjorn Gunnar Erik Evert; Taxis, Katja (European journal of clinical pharmacology, 2022)
      Poor persistence to antihypertensive therapy is an important cause of treatment failure. Investigating persistence is especially important in countries with a high cardiovascular mortality, like Lithuania. The aim of this ...

    • One-year treatment non-persistence rates in hypertensive patients in Lithuania 

      Trečiokienė, Indrė; Bratčikovienė, Nomeda; Gulbinovič, Jolanta; Wettermark, Bjorn Gunnar Erik Evert; Taxis, Katja (Research in social and administrative pharmacy: Conference Abstracts: Next Chapter in Patient Care 2021: patient-centered approach and digital innovation inhealthcare (NCPC 2021) 7-9 April 2022, Parnu, Estonia, 2022)

    • The initiation of treatment and one-year treatment non-persistence rates in hypertensive patients in Lithuania 

      Trečiokienė, Indrė; Bratčikovienė, Nomeda; Gulbinovič, Jolanta; Wettermark, Bjorn; Taxis, Katja (Pharmacoepidemiology and drug safety: Supplement: Abstracts of the 38th International Conference on Pharmacoepidemiology: Advancing Pharmacoepidemiology and Real-World Evidence for the Global Community, August 26–28, 2022, Copenhagen, Denmark, 2022)
      There is extensive evidence on benefits of antihypertensive treatment, yet many patients with hypertension do not reach therapy goals. Poor persistence to antihypertensive drug therapy has shown to be an important reason ...

    • Trend of antihypertensive medicine use in the Baltic States between 2008 and 2018: a retrospective cross-national comparison 

      Trečiokienė, Indrė; Bratčikovienė, Nomeda; Gulbinovič, Jolanta; Wettermark, Bjorn Gunnar Erik Evert; Taxis, Katja (Pharmacoepidemiology, 2022)
      High blood pressure is a major risk factor contributing to death and disability rates in the Baltic states. The aim of this study was to compare the utilization of antihypertensive medicines in Estonia, Latvia and Lithuania ...